Home/Filings/4/0001638599-19-000525
4//SEC Filing

Yoshida Shuhei 4

Accession 0001638599-19-000525

CIK 0001682639other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:19 PM ET

Size

11.2 KB

Accession

0001638599-19-000525

Insider Transaction Report

Form 4
Period: 2019-05-14
Yoshida Shuhei
Director10% Owner
Transactions
  • Exercise/Conversion

    Common Stock, par value $.0001

    2019-05-14$1.95/sh+33,334$65,00133,334 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-1433,3340 total
    Exercise: $1.95Exp: 2027-07-07Common Stock (33,334 underlying)
Holdings
  • Common Stock, par value $.0001

    (indirect: By Senju Pharmaceuticals Co., Ltd.)
    1,718,566
Footnotes (2)
  • [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F2]The option became exercisable as to 2,778 shares on August 7, 2017, and becomes exercisable in equal 2,778 share amounts on each of the 11 one-month anniversaries thereafter.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001728901

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:19 PM ET
Size
11.2 KB